WallStreetZenWallStreetZen

NASDAQ: INMB
Inmune Bio Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Inmune Bio earnings were -$41.6M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. The latest INMB earnings report on Mar 31, 2026 announced Q1 2026 earnings of -$5.4M, up 2.7% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, INMB reported annual earnings of -$45.9M, with 9.2% growth. The next INMB earnings date is Aug 6, 2026.

INMB earnings history

Current Revenue
$0.0
Current Earnings
-$41.6M
Current Profit Margin
0%

INMB Return on Equity

Current Company
-170.9%
Current Industry
-141.9%
Current Market
13.5%
INMB's Return on Equity (-170.9%)... subscribe to Premium to read more.
High Return on Equity Performance

INMB Return on Assets

Current Company
-128.8%
Current Industry
-13.7%
INMB is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when INMB announces earnings.

INMB Return on Capital Employed

Current Company
-203.63%
Current Industry
-9.5%
INMB's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

INMB vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
INMB-$41.47M-$41.60MN/A-$1.67
APLM-$10.62M-$10.94MN/A-$7.57
GRCE-$9.49M-$7.79MN/A-$0.47
CRVO-$30.04M-$30.04MN/A-$3.28
GNTA-$7.47M-$7.51MN/A-$0.38
View Top Biotech Stocks

INMB earnings dates

Next earnings date
Aug 6, 2026

Inmune Bio Earnings Reports & History FAQ

What were Inmune Bio's earnings last quarter?

Inmune Bio (NASDAQ: INMB) reported Q1 2026 earnings per share (EPS) of -$0.20, up 53.49% year over year. Total INMB earnings for the quarter were -$5.41 million. In the same quarter last year, Inmune Bio's earnings per share (EPS) was -$0.43.

If you're new to stock investing, here's how to buy Inmune Bio stock.

When does Inmune Bio report earnings?

The next INMB earnings date is Invalid Date. Add INMB to your watchlist to be reminded of Inmune Bio's next earnings date.

Is Inmune Bio profitable or losing money?

As of the last Inmune Bio earnings report, Inmune Bio is currently losing money. Inmune Bio's net profit (also called net income) for the twelve months ending Mar 31, 2026 was -$41.60 million, a 1.97% increase year over year.

What was INMB's earnings growth in the past year?

As of Inmune Bio's earnings date in Q2 2026, Inmune Bio's earnings has grown year over year. INMB earnings in the past year totalled -$41.60 million.

What are Inmune Bio's earnings expectations?

The current EPS estimate for Inmune Bio's earnings report in Invalid Date is -$0.20.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.